Baird Says Buy The Open, Sell The Launch on Shares of Human Genome Sciences (HGSI)
Tweet Send to a Friend
Baird is reiterating their Outperform rating and $32 price target on shares of Human Genome Sciences (NASDAQ: HGSI) following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
